Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA
Ala. Hautkappe et al., Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA, CANCER RES, 60(12), 2000, pp. 3170-3174
By establishing sensitive nested reverse transcription-PCRs for the detecti
on of nRNA of alpha-fetoprotein (AFP) and beta human chorionic gonadotropin
(beta bCG), we investigated the presence of circulating tumor cells in the
peripheral blood of 119 patients with germ-cell tumor. A total of 336 bloo
d samples obtained before and during therapy were examined with regard to c
linical applicability. The overall ratio of positive PCR results was 26.5%
and was independent of the serum concentration of and hCG/beta hCG. No corr
elation of the positivity for AFP-mRNA to serum AFP level was found. In con
tract, positive results in beta hCG-PCR a ere twice as frequent in patients
with elevated serum hCG/beta bCG levels as in those with normal serum hCG/
beta hCG levels (P = 0.012). To develop a valid correlation to tumor stage,
tumor histology, and serum level of tumor markers, a subgroup of 36 patien
ts was evaluated before definite therapy. The subgroup revealed an overall
ratio of 33.3% positive PCR results. The serum level of both of the markers
did not correlate with the detection of corresponding mRNA in peripheral b
lood samples. However, positive beta hCG-PCR results were found exclusively
in patients with elevated serum hCG/beta hCG (6 of 18 versus 0 of 18; P =
0.019). Patients with stage IIC/III germ-cell tumor demonstrated nearly twi
ce the frequently of positive PCR results as patients with stage I tumor [7
(41.2%) of 17 versus 4 (23.5%) of 17] in this subgroup. With regard to his
tology, positive PCR results were found mostly in embryonal carcinoma.